Skip to main content
. 2019 Jun 2;16(6):845–853. doi: 10.7150/ijms.32505

Table 6.

Adverse events: Number of subjects reported adverse events in the study groups

Adverse events Placebo (n=29) NXT15906F6 250 mg (n=30) NXT15906F6 400 mg (n=30)
Indigestion 01 00 00
Vomiting 01 00 00
Headache 02 00 00
Common cold 04 02 01
Cough 00 01 00
Fever 00 01 01
Body pain 01 00 00
Total no. of subjects (group wise) 09 04 02